US Patent 7449457 Substituted heterocyclic carboxamides with antithrombotic activity
Patent 7449457 was granted and assigned to Eli Lilly and Company on November, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Infobox
Patent Inventor Names
Angela Lynn Marquart0
Anne Louise Tebbe0
David Kent Herron0
David Mendel0
Gerald Floyd Smith0
John Joseph Masters0
Michael Robert Wiley0
Philip Parker Waid0
Sajan Joseph0
Ying Kwong Yee0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+283 characters)
Article
Patent abstract
This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07449457 Substituted heterocyclic carboxamides with antithrombotic activity US Patent 7449457 Substituted heterocyclic carboxamides with antithrombotic activity
Infobox
Patent Number
07449457
Patent Number
7449457
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07449457 Substituted heterocyclic carboxamides with antithrombotic activity
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07449457
Date of patent
November 11, 2008
Patent application number
10497250
Date Filed
December 2, 2002
Patent primary examiner
Find more entities like US Patent 7449457 Substituted heterocyclic carboxamides with antithrombotic activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
